Clinical characteristics and factors associated with in-hospital mortality in patients with Stenotrophomonas maltophilia infection: a single-center retrospective cohort study - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Clinical Features and Determinants of In-Hospital Mortality in Patients with Stenotrophomonas maltophilia Infections: A Retrospective Cohort Analysis from a Single Center
Clinical Scorecard: Clinical Features and Determinants of In-Hospital Mortality in Patients with Stenotrophomonas maltophilia Infections: A Retrospective Cohort Analysis from a Single Center
At a Glance
Category
Detail
Condition
Stenotrophomonas maltophilia infection
Key Mechanisms
Intrinsic multidrug resistance, host vulnerability, and illness severity.
Target Population
Immunocompromised or critically ill individuals with confirmed S. maltophilia infection.
Care Setting
Tertiary hospital
Key Highlights
In-hospital mortality rate was 11.8% among the cohort.
Older age and higher Charlson Comorbidity Index (CCI) values were associated with increased mortality.
Mechanical ventilation was strongly associated with mortality but did not reach statistical significance.
Previous carbapenem exposure did not differ in mortality outcomes.
High in vitro activity was noted for minocycline, cefoperazone/sulbactam, doxycycline, and tigecycline.
Guideline-Based Recommendations
Diagnosis
Confirm S. maltophilia infection through clinical and microbiological evaluation.
Management
Prioritize early risk stratification and thorough evaluation of comorbidity burden.
Monitoring & Follow-up
Monitor for signs of septic shock and organ failure.
Risks
Increased mortality linked to advanced age, comorbidity burden, and mechanical ventilation.
Patient & Prescribing Data
458 inpatients with confirmed S. maltophilia infection.
Empirical therapy should be informed by local susceptibility patterns.
Clinical Best Practices
Initiate prompt supportive care for critically ill patients.
Evaluate appropriateness of empirical antimicrobial therapy based on susceptibility testing.